DCT Tracker update: decentralised clinical trials to reach new peak
Clinical Trials Arena updates its exclusive DCT tracker and projects record trial decentralisation uptake after a minor respite in 2022.

Clinical Trials Arena updates its exclusive DCT tracker and projects record trial decentralisation uptake after a minor respite in 2022.
The Phase I/II clinical trial will evaluate the safety and immunogenicity of the vaccine.
The global pharmaceutical industry experienced a 10% rise in new job postings related to social responsibility in Q3 2022 compared…
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Dyadic initiates subject dosing in Phase I trial of Covid-19 booster
Tevogen Bio reports positive data from Covid-19 T cell therapy trial
Cyrano to initiate Phase II trial of nasal spray therapy for Hyposmia
Shionogi commences Phase I/II/III and Phase III trials of Covid-19 vaccine